![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Mylan Doesn't Have to Recall Already-Shipped Generic Precedex in 'Carve-Out' Row with Hospira
Mylan Doesn't Have to Recall Already-Shipped Generic Precedex in 'Carve-Out' Row with Hospira
A federal court has ruled that generic manufacturer Mylan does not have to recall its already-shipped versions of Hospira’s sedative Precedex, a move that reverses the court’s earlier mandate to recall all existing generic versions of the drug.
Drug Industry Daily
Upcoming Events
-
11Jul
-
18Jul
-
21Oct